Researchers enhance cancer detection and monitoring through blood tests by refining liquid biopsy techniques. Improved sensitivity allows the identification of minute amounts of circulating tumor DNA, RNA, or proteins, providing insights into cancer presence and characteristics. Advanced technologies, like next-generation sequencing, enable detailed genomic profiling for personalized treatment strategies. Regular blood tests facilitate real-time monitoring of treatment response and potential relapse. This non-invasive approach revolutionizes cancer management, offering earlier detection, personalized interventions, and dynamic tracking of disease evolution through accessible and minimally invasive means.
